Physician

Alexander Hartwell Nowlin, M.D.

According to 2025 Medicare claims, Alexander Nowlin, M.D. (NPI: 1952716607) practices pain management in the Mount Vernon-Anacortes, WA market, with the plurality of this provider's patient population coming from Skagit, WA. This provider's primary affiliated billing organization is SOUND PAIN ALLIANCE (NPI: 1649776394; TIN: 823663428) and primary practice location at 98226-9077.

Nowlin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 317 traditional Medicare patients, billed 7,392 HCPCS/CPT codes, and received $168,916 in Medicare payments. The top billing code was G0481 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 2,316 prescription claims across 211 beneficiaries totaling $158,601 in drug costs, led by Oxycontin (Oxycodone Hcl). Open Payments data shows 54 records totaling $1,450. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $5,994 to $158,601. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	195	662	$55,153
2020	319	2,714	$177,737
2021	322	2,759	$199,914
2022	336	2,616	$152,934
2023	320	2,509	$158,930
2024	317	7,392	$168,916

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	46	$5,994
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	52	100	$8,855
2019	242	988	$61,976
2020	376	3,534	$208,013
2021	281	3,433	$193,499
2022	257	2,668	$168,993
2023	271	2,783	$171,676
2024	211	2,316	$158,601

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	58	105	$152
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	86	325	$91
80307	Testing for presence of drug, by chemistry analyzers	74	147	$60
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	83	450	$47
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	58	70	$19

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	47	1,285	$32,486
Xtampza Er	Oxycodone Myristate	56	1,505	$32,022
Belbuca	Buprenorphine Hcl	22	616	$14,322
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	330	8,871	$13,152
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	369	9,880	$10,743

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$1,450	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander Hartwell Nowlin, M.D.?

Tedicare shows public-source Medicare data for Alexander Hartwell Nowlin, M.D. (NPI 1952716607), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Hartwell Nowlin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander Hartwell Nowlin, M.D.?

Alexander Hartwell Nowlin, M.D. is linked to SOUND PAIN ALLIANCE (billing NPI 1649776394) in the available physician profile data.

Does Alexander Hartwell Nowlin, M.D. have Open Payments data?

Alexander Hartwell Nowlin, M.D. has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.